Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014, New Report Launched

Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Publisher team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope:

• A snapshot of the global Market therapeutics scenario for Neuropathic Pain.
• A review of the marketed products under prescription for Neuropathic Pain, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Neuropathic Pain with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Neuropathic Pain drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Neuropathic Pain drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Neuropathic Pain drugs.
• Coverage of Neuropathic Pain Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

Reasons to buy 

• Evaluate the marketing status and exclusivity details of Neuropathic Pain key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Neuropathic Pain.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Neuropathic Pain.
• API intelligence over marketed drugs for Neuropathic Pain and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Neuropathic Pain.
• Uncovering opportunities in the rapidly growing the US markets.

Spanning over 100 pages, “Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” report covering the Indication Overview, Marketed Drugs Assessment, Marketed Drugs Information, Company Overview. The report covered companies are - Pfizer Inc., Eli Lilly and Company, Endo Health Solutions Inc., NeurogesX, Inc., Chart Medical, Inc., APP Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc.

Know more about this report at – http://mrr.cm/ZbM

Related Reports:

1st - Non-Small Cell Lung Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 - visit at: http://mrr.cm/ZbQ

2nd - Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 - visit at: http://mrr.cm/ZbA

3rd - Blood Coagulation Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 - visit at: http://mrr.cm/Zbd

To browse more market research reports by Delveinsight visit: 

http://www.marketresearchreports.com/publisher/delveinsight

Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014, New Report Launched

Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors-Pipeline Insights, 2014 report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors. This report provides information on the therapeutic development based on the Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Publisher team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• The report provides a snapshot of the global therapeutic landscape of Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy

• Complete MOA intelligence and complete understanding over therapeutics development for Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Spanning over 60 pages, “Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014” report covering the Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors Overview, Comparative Analysis, Drug Candidate Profiles, Appendix, Methodology

Know more about this report at – http://mrr.cm/ZbP

Related Reports:

1st - Dihydropteroate Synthetase (DHPS) Inhibitors -Pipeline Insights, 2014 - visit at: http://mrr.cm/ZbW

2nd - DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2014 - visit at: http://mrr.cm/Zbm

3rd - HIV Attachment Inhibitor -Pipeline Insights, 2014 - visit at: http://mrr.cm/Zbs

To browse more market research reports by Delveinsight visit: http://www.marketresearchreports.com/publisher/delveinsight

B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2014, New Report Launched

B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2014 report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under B-Cell Chronic Lymphocytic Leukemia. This report provides information on the therapeutic development based on the B-Cell Chronic Lymphocytic Leukemia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Data Sources

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• The report provides a snapshot of the global therapeutic landscape of B-Cell Chronic Lymphocytic Leukemia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the B-Cell Chronic Lymphocytic Leukemia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for B-Cell Chronic Lymphocytic Leukemia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy

• Complete Pipeline intelligence and complete understanding over therapeutics development for B-Cell Chronic Lymphocytic Leukemia
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding B-Cell Chronic Lymphocytic Leukemia pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Spanning over 60 pages, “B-Cell Chronic Lymphocytic Leukemia-Pipeline Insights, 2014” report covering the B-Cell Chronic Lymphocytic Leukemia Overview, Comparative Analysis, Drug Candidate Profiles, Appendix and Methodology.

Know more about this report at – http://mrr.cm/Zbc

Related Reports:

1st - B-Cell Leukemia-Pipeline Insights, 2014 - visit at: http://mrr.cm/Zbp

2nd - B-Cell Lymphomas-Pipeline Insights, 2014 - visit at: http://mrr.cm/ZbG

3rd - B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2014 - visit at: http://mrr.cm/ZbN

To browse more market research reports by Delveinsight visit: http://www.marketresearchreports.com/publisher/delveinsight

United Kingdom General Surgery Market Outlook to 2020, New Report Launched

United Kingdom General Surgery Market Outlook to 2020 report provides key market data on the United Kingdom General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available.

The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size and company share data for General Surgery devices categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.
• Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2013 and forecast to 2020.
• 2013 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the United Kingdom General Surgery devices market.
• Key players covered include Olympus Corporation, Ethicon, Covidien, B. Braun Melsungen AG, C.R. Bard, Inc., and KARL STORZ GmbH & Co. KG.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Spanning over 472 pages, “United Kingdom General Surgery Market Outlook to 2020” report covered 16 companies - Olympus Corporation, KARL STORZ GmbH & Co. KG, C. R. Bard, Inc., Covidien plc, B. Braun Melsungen AG, PENTAX Medical Company, Hologic, Inc., Johnson & Johnson, Cook Group Incorporated, CareFusion Corporation, Ethicon Endo-Surgery, Inc., Boston Scientific Corporation, Devicor Medical Products, Inc., Fujifilm Holdings Corporation, Intuitive Surgical, Inc., Stryker Corporation

Know more about this report at – http://mrr.cm/Zbq

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

India General Surgery Market Outlook to 2020, New Report Launched

India General Surgery Market Outlook to 2020 report provides key market data on the India General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available.

The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size and company share data for General Surgery devices categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.
• Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2013 and forecast to 2020.
• 2013 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the India General Surgery devices market.
• Key players covered include Olympus Corporation, Ethicon, Covidien, B. Braun Melsungen AG, C.R. Bard, Inc., and KARL STORZ GmbH & Co. KG.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Spanning over 422 pages, “India General Surgery Market Outlook to 2020” report covered 16 companies - Olympus Corporation, KARL STORZ GmbH & Co. KG, C. R. Bard, Inc., Hologic, Inc., Stryker Corporation, Cook Group Incorporated, CareFusion Corporation, Covidien plc, B. Braun Melsungen AG, Johnson & Johnson, Boston Scientific Corporation, Devicor Medical Products, Inc., PENTAX Medical Company, Fujifilm Holdings Corporation, Intuitive Surgical, Inc., Om Surgicals

Know more about this report at – http://mrr.cm/Zbi

Related Reports:

1st - Australia General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/Zb5

2nd - Japan General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/ZbS

3rd - China General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/ZbT

United States General Surgery Market Outlook to 2020, New Report Launched

United States General Surgery Market Outlook to 2020 report provides key market data on the United States General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available.

The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size and company share data for General Surgery devices categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.
• Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2013 and forecast to 2020.
• 2013 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the United States General Surgery devices market.
• Key players covered include Olympus Corporation, Ethicon, Covidien, B. Braun Melsungen AG, C.R. Bard, Inc., and KARL STORZ GmbH & Co. KG.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Spanning over 1451 pages, “United States General Surgery Market Outlook to 2020” report covered 18 companies - Olympus Corporation, Covidien plc, Intuitive Surgical, Inc., C. R. Bard, Inc., Ethicon Endo-Surgery, Inc., KARL STORZ GmbH & Co. KG, Hologic, Inc., PENTAX Medical Company, CareFusion Corporation, Johnson & Johnson, Cook Group Incorporated, Conceptus, Inc., Devicor Medical Products, Inc., Boston Scientific Corporation, Fujifilm Holdings Corporation, Given Imaging Ltd., B. Braun Melsungen AG, Stryker Corporation

Know more about this report at – http://mrr.cm/Zb3

Related Reports:

1st - Brazil General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/ZbU

2nd - Mexico General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/Zbw

Italy General Surgery Market Outlook to 2020, New Report Launched

Italy General Surgery Market Outlook to 2020 report provides key market data on the Italy General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the General Surgery devices market wherever available.

The data in the report is derived from dynamic market forecast models. Publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size and company share data for General Surgery devices categories Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.
• Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2013 and forecast to 2020.
• 2013 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the Italy General Surgery devices market.
• Key players covered include Olympus Corporation, Ethicon, Covidien, B. Braun Melsungen AG, C.R. Bard, Inc., and KARL STORZ GmbH & Co. KG.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Spanning over 408 pages, “Italy General Surgery Market Outlook to 2020” report covered 18 companies - Olympus Corporation, C. R. Bard, Inc., Covidien plc, KARL STORZ GmbH & Co. KG, B. Braun Melsungen AG, Johnson & Johnson, Hologic, Inc., PENTAX Medical Company, Cook Group Incorporated, Devicor Medical Products, Inc., Fujifilm Holdings Corporation, Intuitive Surgical, Inc., CareFusion Corporation, Boston Scientific Corporation, Stryker Corporation, Syneron Medical Ltd., Ethicon Endo-Surgery, Inc., Cynosure, Inc.

Know more about this report at – http://mrr.cm/ZLv

Related Reports:

1st - South Korea General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/Zbk

2nd - Russia General Surgery Market Outlook to 2020 - visit at: http://mrr.cm/ZbZ

Find all Medical Devices Reports: http://www.marketresearchreports.com/medical-devices